Robert Weinkove

University of Auckland — New Zealand

Medicine · Health Sciences

29h-index4.2kcitations128works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(40), CAR-T cell therapy research(32), Immune Cell Function and Interaction(25), Lymphoma Diagnosis and Treatment(18), Immunodeficiency and Autoimmune Disorders(18)

Publications128 total

Blood tests to predict CAR T-cell toxicity and efficacy
Blood Advances·2026Open Access
Frontline treatment of sonrotoclax (BGB-11417) and zanubrutinib for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) demonstrates high undetectable minimal residual disease (uMRD) rates with favorable tolerability: Updated data from BGB-11417-101, an ongoing phase 1/1b study
Blood·2025Open Access
Primary cutaneous gamma-delta T-cell lymphoma presenting with vulvar mass
International Journal of Gynecological Cancer·2025
Research priorities to address supportive care needs in acute myeloid leukaemia (AML)—results from a Delphi survey
Supportive Care in Cancer·2025Open Access
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
Blood·2025· 1 citedOpen Access
Jurkat T-cell lines exhibit marked genomic instability affecting karyotype, mutational profile, gene expression, immunophenotype and function
Scientific Reports·2025· 3 citedOpen Access
49 | COMBINATION TREATMENT WITH NOVEL BCL2 INHIBITOR SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB INDUCES HIGH RATE OF COMPLETE REMISSION IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Hematological Oncology·2025· 1 citedOpen Access
214 | FINAL INDEPENDENT REVIEW DATA SUPPORTS SUSTAINED BENEFIT OF ZANUBRUTINIB OVER IBRUTINIB IN PATIENTS WITH R/R CLL/SLL IN ALPINE
Hematological Oncology·2025· 1 citedOpen Access
A phase 2 trial to evaluate the efficacy and safety of WZTL-002, a third-generation anti-CD19 CAR T-cell therapy, in patients with relapsed or refractory large B-cell lymphoma (ENABLE-2).
Journal of Clinical Oncology·2025
CD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects
Cell Reports Medicine·2025· 4 citedOpen Access
Abstract A018: Functional, transcriptomic and genomic characterisation of CD19-directed CAR T-cells incorporating a TLR2 co-stimulatory domain
Cancer Immunology Research·2025
Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma
Frontiers in Immunology·2024· 2 citedOpen Access
PD23 Economic Evaluation Of Prophylactic Immunoglobulin Versus Prophylactic Antibiotics In Hematological Malignancies: Results From The RATIONAL Feasibility Trial
International Journal of Technology Assessment in Health Care·2024Open Access
Sonrotoclax and Zanubrutinib as Frontline Treatment for CLL Demonstrates High MRD Clearance Rates with Good Tolerability: Data from an Ongoing Phase 1/1b Study BGB-11417-101
Blood·2024· 12 citedOpen Access
A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)
Blood·2024· 2 citedOpen Access
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE
Blood·2024· 45 citedOpen Access
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study
Blood·2024· 94 citedOpen Access
Tuning CAR T-cell therapies for efficacy and reduced toxicity
Seminars in Hematology·2024· 9 cited
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Internal Medicine Journal·2024Open Access
A NOVEL MODIFIED CD20 PROTEIN DOUBLES AS A DETECTION TAG AND SAFETY SWITCH FOR ADOPTIVE CELL THERAPIES.
Cytotherapy·2024
page 1 of 7Next →

Frequent Co-authors

Ian F. Hermans(15), Barbara Eichhorst(10), Constantine S. Tam(9), Gavin F. Painter(9), Kirsten Fischer(7), Eugen Tausch(7), Matthias Ritgen(7), Stephan Stilgenbauer(7), Michael Hallek(7), Othman Al‐Sawaf(6), Zoe McQuilten(6), Stephen Opat(5), Liliya Sivcheva(5), Carsten Utoft Niemann(5), Tadeusz Robak(5), Nathaniel Dasyam(5), Erica M. Wood(5), Peng Li(5), Benjamin J. Compton(5), Astrid Authier-Hall(5)